Quarterly Sales and EPS Roundup:
Tenet Healthcare Corporation (THC) reported sales (ttm) of 19.39 Billion, whereas, 15 number of analysts estimated the mean sale of 4895.74 million. The analysts estimated sales for the higher end at 4986 million and lower end at 4836 million while the year ago reported sale was 4976.5 million.
15 number of analysts have estimated the sales of the company for the quarter ending Jul 31, 2017- Aug 4, 2017, analysts estimated mean sale target of 4908.34 million while high and low sale targets are estimated at 5030 million and 4749.51 million respectively.
Tenet Healthcare Corporation (THC) reported earning per shares for the quarter ending May 01 AMC at -0.27, whereas, 17 number of analysts estimated the mean EPS at -0.18. The analysts estimated EPS for the higher end at 0.05 and lower end at -0.39 while the year ago reported earnings per share was 0.65.
The company has mean EPS estimate of 0.07 reported by 17 number of analyst for the quarter ending Jul 31, 2017- Aug 4, 2017. The analysts estimated mean EPS at 0.07 while the high and low EPS estimate stand at 0.41 and -0.22 respectively. In contrast to the year ago quarter EPS was at 0.6. EPS long term mean growth rate estimated by 6 analysts is at 20.3%, whereas, the high and low Long term growth rate estimated at 36.4 and 5.1.
Valuation Ratios of Tenet Healthcare Corporation (THC) versus the Industry and Sector:
Let’s have a look at some of the important valuation ratios of the Tenet Healthcare Corporation (THC). These ratios are important while doing valuation of the company or the shares of the company.
Tenet Healthcare Corporation (THC) currently has P/E (Price to Earnings) ratio of 0 while the company’s industry has 31.45 P/E and the sector P/E is 17.99. Similarly, the company’s last 5 years high P/E ratio is 149.31 and low P/E is 19.12, whereas, the industry’s and sector’s high P/E for the past year is 73.62 and 42.93 respectively and low P/E ratio for the last 5 years is 49.16 for the industry and 23.07 for the Sector.
Beta is also an important valuation ratio for analyzing the stock of the company, THC has Beta of 1.32 while its industry and Sector’s beta remains at 0.51 and 0.86 respectively.
Price to Sale ratio of THC stands at 0.09 while Price to Book Ratio stands at 4.03. Its Price to Cash Flow ratio shows the value of 1.67, whereas, the industry and sector ratio of Price to Cash Flow ticked at 22.21 and 11.47 respectively.
5 Year Growth Rate Analysis:
Growth rates are very important while analyzing the long term growth and valuation of a certain company.
5 year sales growth rate is an important factor for valuation analysis, the 5 year sales growth of Tenet Healthcare Corporation (THC) stands at 17.79 while the industry’s and the sector’s growth for next 5 years ticked at 17.04 and 10.42 respectively. The company’s 5 year Earnings per share growth and Capital Spending growth remains at 0 and 13.38.
Tenet Healthcare Corporation (THC) Trading Statistics:
The company declined -1.68% and closed its last trading session at $17.27. The market capitalization of the company is at $1.73 Billion. The stock touched 52-week High of $31.84 on 07/21/16 and 52-week Low of $14.06 on 11/11/16. The stock currently has Weekly Volatility of 3.76% and Monthly Volatility of 4.79%. The Beta for the company stands at 1.36 and its Average True Range (ATR) shows a value of 0.81.